Correlation Between Sarofim Equity and Fidelity Series

Can any of the company-specific risk be diversified away by investing in both Sarofim Equity and Fidelity Series at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarofim Equity and Fidelity Series into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sarofim Equity and Fidelity Series 1000, you can compare the effects of market volatilities on Sarofim Equity and Fidelity Series and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarofim Equity with a short position of Fidelity Series. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarofim Equity and Fidelity Series.

Diversification Opportunities for Sarofim Equity and Fidelity Series

0.68

Correlation Coefficient

Sarofim Equity  Fidelity Series

Poor diversification

The 3 months correlation between Sarofim and Fidelity is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Sarofim Equity and Fidelity Series 1000 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fidelity Series 1000 and Sarofim Equity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarofim Equity are associated (or correlated) with Fidelity Series. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fidelity Series 1000 has no effect on the direction of Sarofim Equity i.e., Sarofim Equity and Fidelity Series go up and down completely randomly.

Pair Corralation between Sarofim Equity and Fidelity Series

Assuming the 90 days horizon Sarofim Equity is expected to under-perform the Fidelity Series. In addition to that, Sarofim Equity is 2.48 times more volatile than Fidelity Series 1000. It trades about -0.15 of its total potential returns per unit of risk. Fidelity Series 1000 is currently generating about -0.1 per unit of volatility. If you would invest  1,712  in Fidelity Series 1000 on October 6, 2024 and sell it today you would lose (68.00) from holding Fidelity Series 1000 or give up 3.97% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	97.62%
Values	Daily Returns

Sarofim Equity  vs.  Fidelity Series 1000

Sarofim Equity

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sarofim Equity has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's primary indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Fidelity Series 1000

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Fidelity Series 1000 has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Fidelity Series is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Sarofim Equity and Fidelity Series

The main advantage of trading using opposite Sarofim Equity and Fidelity Series positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarofim Equity position performs unexpectedly, Fidelity Series can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fidelity Series will offset losses from the drop in Fidelity Series' long position.

The idea behind Sarofim Equity and Fidelity Series 1000 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..